Wednesday, September 4, 2013

Rockwell Medical's iron deficiency drug succeeds in second late-stage study

(Reuters) - Rockwell Medical Inc said its lead experimental drug met the main goal of improving hemoglobin levels in its final late-stage trial among adult patients with chronic kidney disease.






No comments:

Post a Comment

Subscribe Now: Feed Icon